ctrl K

Watchlist Price Alert

Meridian Bioscience Inc. (VIVO)

NASDAQ: VIVO · Real-Time Price · USD

33.97

0.00 (0.00%)

At close: Jan 30, 2023, 10:00 PM

Meridian Bioscience Income Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Revenue	333.02M	317.9M	253.67M	201.01M	213.57M	200.77M	196.08M
Cost of Revenue	144.66M	116.75M	97.42M	82.69M	83.11M	75.94M	68.3M
Gross Profit	188.36M	201.15M	156.25M	118.33M	130.46M	124.83M	127.79M
Operating Income	55.51M	93.03M	61.32M	32.7M	31.58M	37.38M	51.38M
Interest Income	17K	n/a	142K	681K	418K	171K	67K
Pretax Income	54.32M	90.45M	59.29M	31.56M	30.38M	36.43M	50.64M
Net Income	42.46M	71.41M	46.19M	24.38M	23.85M	21.56M	32.23M
Selling & General & Admin	88.42M	79.12M	72.91M	63.03M	68.96M	65.14M	60.44M
Research & Development	24.34M	23.91M	23.73M	17.95M	16.87M	15.68M	13.81M
Other Expenses	-350K	4.6M	n/a	n/a	n/a	n/a	n/a
Operating Expenses	112.41M	107.63M	96.64M	80.98M	85.83M	80.82M	74.25M
Interest Expense	1.19M	1.88M	2.63M	1.95M	1.52M	1.64M	897K
Selling & Marketing Expenses	31.27M	26.78M	26.49M	28.45M	34.47M	32.1M	29.87M
Cost & Expenses	257.07M	224.38M	194.06M	163.67M	168.94M	156.76M	142.55M
Income Tax Expense	11.86M	19.04M	13.11M	7.17M	6.53M	14.87M	18.41M
Shares Outstanding (Basic)	44.01M	44.01M	43.17M	42.9M	42.75M	42.19M	42.01M
Shares Outstanding (Diluted)	44.01M	44.01M	43.17M	42.9M	42.75M	42.57M	42.39M
EPS (Basic)	0.96	1.62	1.07	0.57	0.56	0.51	0.77
EPS (Diluted)	0.96	1.62	1.07	0.57	0.56	0.51	0.76
EBITDA	72.02M	107.61M	75.49M	43.47M	39.82M	46.19M	58.17M
EBIT	n/a	92.33M	61.92M	33.5M	31.9M	38.07M	51.54M
Depreciation & Amortization	16.51M	15.29M	13.57M	9.96M	7.92M	8.12M	6.63M